Navigation Links
Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
Date:10/8/2007

SALT LAKE CITY, Utah - Mario R. Capecchi, Ph.D., distinguished professor of human genetics and biology at the University of Utahs Eccles Institute of Human Genetics and a Howard Hughes Medical Institute investigator, has won the 2007 Nobel Prize in Physiology or Medicine.

The announcement was made this morning by the Nobel Assembly at the Karolinska Institute, in Stockholm, Sweden. The prize recognizes Capecchis pioneering development of knockout mice technology, a gene-targeting technique that has revolutionized the study of mammalian biology and allowed the creation of animal models for hundreds of human diseases, including the modeling of cancers in the mouse.

Capecchi shared the Noble prize with Oliver Smithies, D.Phil., of the University of North Carolina, Chapel Hill, and Sir Martin Evans, Ph.D., at the University of Cardiff, Wales.

The Nobel committee cited the three for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells.

This is a tremendous honor for our University, for our Department of Human Genetics, and, specifically, for all the members of my laboratory, past and present who have contributed to this work, said Capecchi upon receiving notification of the Nobel Prize early this morning. The strong support and genuine interest of the University and Salt Lake City communities have been marvelous.

It is a great honor to share this prize with Drs. Oliver Smithies and Martin Evans. We have all been very fortunate in having a longstanding scientific friendship and in being able to profoundly contribute to each others work. This prize is a tribute to our collective efforts.

The Nobel tops a long list of prestigious honors for Capecchi, who, as a child, was forced to wander four years on the streets of Italy after the Nazis imprisoned his mother in a concentration camp. His achievements in gene targeting were recognized with
'/>"/>

Contact: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site
2. Researchers pioneer new gene therapy technique using natural repair process
3. Diabetes researchers pioneer islet cell xenotransplantation in primate studies
4. Rice bioengineers pioneer techniques for knee repair
5. Nobelist discovers antidepressant protein in mouse brain
6. Comments, experts and background on the 2006 Nobel Prize in chemistry
7. Nobel Laureate finds elegant explanation for DNA transcribing enzymes high fidelity
8. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
9. LEGO-Like building blocks to halt cell growth wins Hebrew University prize
10. Australian wins prestigious prize in biodiversity informatics
11. Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... --  Guidepoint , a leading global research services firm, ... TRACKER, part of the Guidepoint TRACKER suite ... device and therapeutics markets. The Post-Surgical Pain Management TRACKER ... share, and adoption rates across three major modalities used ... The Post-Surgical Pain Management TRACKER will provide length ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... the "Global Iris Recognition Market 2015-2019" report ... Global Iris Recognition market to grow at a CAGR ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ... solutions, today announced that its U.are.U ® ... retailer Goorin Bros . to achieve PCI ... solution secures access to the POS terminal, protecting ... risk of data breaches. With ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... how an invading virus hijacks a cell,s workings by ... By manipulating cell signals, the virus destroys a defensive ... in human cell cultures, may represent a broader targeting ... scientific groundwork for developing more effective treatments for infectious ...
... 2012) Autism Speaks, the world,s leading autism science ... research grants totaling $1.1 million in funding to support ... of Autism Speaks, continued funding for novel research projects ... understanding autism," said Autism Speaks Co-founder Bob Wright. ...
... radiology treatment, prostatic artery embolization, may bring hope to ... say the group of researchers who pioneered its use. ... Radiology,s 37th Annual Scientific Meeting in San Francisco, Calif. ... many men over the age of 50, and these ...
Cached Biology News:To drive infections, a hijacking virus mimics a cell's signaling system 2Autism Speaks awards $1.1 million to fund high priority studies 2Autism Speaks awards $1.1 million to fund high priority studies 3Interventional radiology: Potential breakthrough to treat men's enlarged prostate 2Interventional radiology: Potential breakthrough to treat men's enlarged prostate 3
(Date:3/31/2015)... Materials in Society Lecture Series at   ...   Elsevier , a world-leading provider of ... home of Materials Today , announced that its ... in Society  Lecture Series . The inaugural lectures ... Conference on Materials for Advanced Technologies (ICMAT) to be ...
(Date:3/31/2015)... LAKE CITY , March 31, 2015  The ... milestone with the selection of ten proposals that ... MCRI is the first patient-led, scientifically validated funding ... Stage 2 of the MCRI included ... careful review of a large number of innovative ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Diasome Pharmaceuticals, ... licensor, SDG, Inc., that a United States patent has ... insulin therapy. , Entitled “Lipid Construct for ... composition of matter claims related to the use of ... for enabling injected insulin to more effectively reach the ...
(Date:3/30/2015)... 2015  Heidrick & Struggles (Nasdaq: HSII ), the ... and culture shaping worldwide, today  announced that ... its global Healthcare and Life Sciences practice. As ... will lead a team of more than 80 partners, principals ... and Asia serving clients in the ...
Breaking Biology Technology:Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 3Myeloma Crowd Research Initiative Selects 10 High-Risk Multiple Myeloma Proposals For Further Review 2Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice 2
... QUEBEC CITY, April 28 /PRNewswire-FirstCall/ - Atrium Innovations ... and webcast at 2:00 p.m.,Eastern time on May ... release of,Atrium,s 2008 first quarter results issued earlier ... the following numbers: 416-644-3416,514-807-8791 or 800-731-5319 or via ...
... 28 ChemDiv, Inc.,a global CRO for ... a biopharmaceutical company developing first-in-class drugs,for the ... the signing,of a collaborative discovery research agreement. ... discover small molecule ligands for biotargets,nominated by ...
... The Netherlands, April 28 , ... Brachytherapy Represents the,Next Generation in DICOM-Compatible, ... a knowledge-based leader in radiation oncology, ... a comprehensive,volume-based treatment planning system to ...
Cached Biology Technology:Atrium Innovations to Hold 2008 First Quarter Financial Results Conference Call and Webcast on May 6 2Syndexa Pharmaceuticals Corporation and ChemDiv, Inc. Announce Discovery Collaboration 2Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment 2
Request Info...
...
... The integration of 2D polyacrylamide gel ... widely regarded as a core technology platform ... resolving power for complex samples limited only ... resolve small and large proteins. Quantitative image ...
... The EC105 power supply is a highly compact, ... A single adjustment knob and one hi-lo range ... 10 volt increments from 20 to 250 volts. ... from indicating output voltage to output current. For ...
Biology Products: